Dec 7, 2023

Vivian DeWoskin, Chief Commercial Officer at NeuraLight, focuses on developing solutions for diagnosing, monitoring and treating neurodegenerative diseases using oculometric data. Using computer vision and deep learning techniques, data from measuring eye position and movement can provide biomarkers for early detection...

Dec 7, 2023

Vivian DeWoskin, Chief Commercial Officer at NeuraLight, focuses on developing solutions for diagnosing, monitoring and treating neurodegenerative diseases using oculometric data. Using computer vision and deep learning techniques, data from measuring eye position and movement can provide biomarkers for early detection...

Dec 4, 2023

Arun Menawat, CEO of Profound Medical, discusses the challenges of treating prostate cancer and how traditional treatments like prostate removal or radiation often result in side effects and complications. While historically, a PSA blood test has been used for diagnosis, an MRI provides a more precise and...

Dec 4, 2023

Arun Menawat, CEO of Profound Medical, discusses the challenges of treating prostate cancer and how traditional treatments like prostate removal or radiation often result in side effects and complications. While historically, a PSA blood test has been used for diagnosis, an MRI provides a more precise and...

Oct 30, 2023

Tim Moran, President and CEO of Avertix, discusses the company's mission to revolutionize how heart attack survivors are cared for and supported. Targeting patients who have had one prior heart attack or instance of a prior acute coronary syndrome, this first-of-its-kind technology is implanted in patients to...